NCT05603403View on ClinicalTrials.gov

Efficacy And Safety Of Probiatop In The Treatment Of Digestive Symptoms

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 20, 2022

Primary Completion Date

March 15, 2023

Study Completion Date

March 15, 2023

Conditions
Signs and Symptoms, Digestive
Interventions
DRUG

Probiatop

1 sachet orally, 2 times a day, for 42 days

OTHER

Placebo

1 sachet orally, 2 times a day, for 42 days

Trial Locations (1)

13271-130

A2Z Clinical Centro Avancado de Pesquisa Clinica Eireli, Valinhos

All Listed Sponsors
collaborator

Farmoquimica S.A.

INDUSTRY

lead

Azidus Brasil

INDUSTRY